Publications de la R&D d'Unicancer

2018

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Luc Cabel et al, Breast Cancer Research and TreatmentJanuary 2019, Volume 173, Issue 2, pp 397–406.

2018

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Elisa Gobbini et al, European Journal of Cancer 96 (2018) 17e24.

2018

GEMO, a national resource to study genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 pathogenic variant carriers

Lesueur F. et al, Front Oncol. 2018 Oct 31;8:490. doi: 10.3389/fonc.2018.00490. eCollection 2018.

2018

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk in Women with BRCA1 and BRCA2 mutations

Terry MB et al, JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.

2018

Efficacy of Anthracycline/taxane based neoadjuvant chemotherapy on Triple-Negative Breast Cancer in BRCA1 / BRCA2 mutation carriers.

Bignon L. et al, Breast J 2018 Volume24, Issue3May/June 2018Pages 269-277. Article DOI: 10.1111/tbj.12887